Manulife (Manufacturers Life Insurance)
NGM

Manulife (Manufacturers Life Insurance)’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,508
Closed -$71.4K – 3088
2023
Q1 		$71.4K Hold
17,508
– – ﹤0.01% 2812
2022
Q4 		$87.9K Buy
17,508
+887
+5% +$5.56K ﹤0.01% 2825
2022
Q3 		$217K Sell
16,621
-342
-2% -$5.18K ﹤0.01% 2533
2022
Q2 		$217K Buy
16,963
+2,267
+15% +$31.4K ﹤0.01% 2613
2022
Q1 		$224K Sell
14,696
-3,168
-18% -$49.4K ﹤0.01% 2696
2021
Q4 		$316 Buy
17,864
+188
+1% +$3.61K ﹤0.01% 2576
2021
Q3 		$372K Sell
17,676
-1,292
-7% -$28.4K ﹤0.01% 2506
2021
Q2 		$374K Buy
18,968
+3,327
+21% +$77.9K ﹤0.01% 2636
2021
Q1 		$455K Buy
15,641
+123
+0.8% +$3.44K ﹤0.01% 2343
2020
Q4 		$470K Buy
15,518
+447
+3% +$9.78K ﹤0.01% 2234
2020
Q3 		$240K Hold
15,071
– – ﹤0.01% 2452
2020
Q2 		$295K Sell
15,071
-1,597
-10% -$30.5K ﹤0.01% 2267
2020
Q1 		$206K Buy
+16,668
New +$272K ﹤0.01% 2308

Other funds holding NGM

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s NGM Position: Q2 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2023, closing a stake of 17,508 shares — an estimated $71.4K sold.

Manulife (Manufacturers Life Insurance) first reported a position in NGM in Q1 2020 and held it in 13 quarters. The position peaked at $470K in Q4 2020. 106 funds tracked by Wall St. Rank hold NGM as of Q2 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 17,508 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $71.4K.
  • Manulife (Manufacturers Life Insurance) first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 13 quarters.
  • Manulife (Manufacturers Life Insurance)'s NGM Biopharmaceuticals, Inc. Common Stock position peaked at $470K in Q4 2020.
  • 106 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2023, filed 11 Aug 2023.